DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG GETS FDA APPROVAL - 7 27 24

THERE HAVE BEEN SEVERAL EXCITING RECENT DEVELOPMENTS REGARDING FDA APPROVAL OF DRUGS USED TO TREAT EARLY ALZHEIMER’S DISEASE. WE SPEAK WITH NIKHIL PALEKAR, MD - DIRECTOR OF THE STONY BROOK CENTER OF EXCELLENCE FOR ALZHEIMER’S DISEASE AND DIRECTOR OF THE STONY BROOK ALZHEIMER’S DISEASE CLINICAL TRIALS PROGRAM.